Cardiovascular Pharmacotherapy Focus

Código QR

Cardiovascular Pharmacotherapy Focus

Guardado en:

Detalles Bibliográficos
Autor principal:	Pablo Avanzas
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/d10ff26d0f3b4a458e2ed6b2720c8e4c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019)

24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
por: Hector Ventura
Publicado: (2020)

Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
por: BMY Cheung, et al.
Publicado: (2020)

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
por: Jonathan Yap, et al.
Publicado: (2021)

Editorial: The EXCEL Trial
por: Pablo Avanzas, et al.
Publicado: (2021)

The ISCHEMIA Trial: And the Winner Is… the Patient
por: Pablo Avanzas, et al.
Publicado: (2021)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
por: Ramón Arroyo-Espliguero, et al.
Publicado: (2021)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Hargun Kaur, et al.
Publicado: (2021)

Meditation and Cardiovascular Health: What is the Link?
por: Sebastian Schnaubelt, et al.
Publicado: (2019)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
por: Amelia Carro, et al.
Publicado: (2019)

COVID-19 Pandemic and Cardiovascular Disease
por: Aniket S Rali, et al.
Publicado: (2020)

The Association Between Psoriasis and Cardiovascular Diseases
por: Ahmed Zwain, et al.
Publicado: (2021)

Effects of aerospace environments on the cardiovascular system
por: Erdinç Ercan
Publicado: (2021)

Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies
por: Tonje Thorvaldsen, et al.
Publicado: (2019)

Porcelain aorta rupture after cardiopulmonary resuscitation
por: Iria Silva, et al.
Publicado: (2021)

Porcelain aorta rupture after cardiopulmonary resuscitation
por: Iria Silva, et al.
Publicado: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
por: Aniket S Rali, et al.
Publicado: (2021)

Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
por: Charalampos Varlamos, et al.
Publicado: (2021)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: Domenico D’Amario, et al.
Publicado: (2019)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
por: Pensée Wu, et al.
Publicado: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
por: Yunqiu Jiang, et al.
Publicado: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
por: Soohyun Chang, et al.
Publicado: (2021)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Gianluigi Savarese
Publicado: (2019)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
por: Ernest Spitzer, et al.
Publicado: (2020)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: BMY Cheung, et al.
Publicado: (2020)